Session Information
2007 Midyear Clinical Meeting
Biosimilar Biologics: Future Impact on Health-System Pharmacy
Track: Educational Session
Program Code: 264-L04
Date: Tuesday, December 4, 2007
Time: 2:30 p.m. - 5:00 p.m.
Location:
Veronese 2403/2404/2503/2504MEETING PLANNING ASSOCIATE:
Dr. James Hoffman, PharmD, MS
MODERATOR:
Ms. Katie Suda, Assistant Professor and Director, University of Tennessee Health Science Center
PRESENTERS:
Dr. James Hoffman, PharmD, MS
Professor Roger Tredree, BPharm, MRPharmSGB, Visiting Professor, Kingston University
Mark Jenkins, Esq., Womble Carlyle Sandridge Rice, PLLC
LEARNING OBJECTIVES
- Describe the potential influence of follow-on (generic) biologics on health-system pharmacy practice.
- Identify barriers to the widespread introduction of follow-on (generic) biologics to the United States market.
- Compare various viewpoints on the key regulatory and safety questions surrounding (generic) biologics.
- Formulate an individual assessment of the issues surrounding key regulatory and safety questions with (generic) biologics.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 264-L04)
This session is a part of: